Arteris, Inc. (NASDAQ:AIP – Get Free Report) major shareholder Bayview Legacy, Llc sold 100,000 shares of the business’s stock in a transaction on Monday, October 6th. The stock was sold at an average price of $13.10, for a total transaction of $1,310,000.00. Following the completion of the transaction, the insider directly owned 9,739,071 shares in the company, valued at $127,581,830.10. This trade represents a 1.02% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
Bayview Legacy, Llc also recently made the following trade(s):
- On Tuesday, August 5th, Bayview Legacy, Llc sold 50,000 shares of Arteris stock. The stock was sold at an average price of $13.12, for a total transaction of $656,000.00.
Arteris Stock Up 4.2%
Arteris stock opened at $13.49 on Thursday. The company has a market cap of $575.35 million, a price-to-earnings ratio of -16.45 and a beta of 1.45. The firm’s fifty day moving average is $9.84 and its 200 day moving average is $8.53. Arteris, Inc. has a 52-week low of $5.46 and a 52-week high of $14.58.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in AIP. Bank of America Corp DE grew its holdings in Arteris by 36.9% during the 4th quarter. Bank of America Corp DE now owns 33,619 shares of the company’s stock worth $343,000 after acquiring an additional 9,068 shares in the last quarter. GAMMA Investing LLC grew its holdings in Arteris by 11,823.3% during the 1st quarter. GAMMA Investing LLC now owns 5,127 shares of the company’s stock worth $350,000 after acquiring an additional 5,084 shares in the last quarter. Cambridge Investment Research Advisors Inc. bought a new position in Arteris during the 1st quarter worth about $95,000. CWM LLC grew its holdings in Arteris by 4,810.1% during the 1st quarter. CWM LLC now owns 10,213 shares of the company’s stock worth $71,000 after acquiring an additional 10,005 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new position in Arteris during the 1st quarter worth about $328,000. 64.36% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts recently issued reports on the stock. Wall Street Zen raised shares of Arteris from a “sell” rating to a “hold” rating in a research note on Monday, September 15th. Weiss Ratings reissued a “sell (d-)” rating on shares of Arteris in a research note on Wednesday. Finally, TD Cowen increased their target price on shares of Arteris from $12.00 to $15.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Three research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Arteris presently has an average rating of “Moderate Buy” and a consensus target price of $15.00.
Get Our Latest Research Report on Arteris
About Arteris
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Articles
- Five stocks we like better than Arteris
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- Retail Stocks Investing, Explained
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- Stock Market Upgrades: What Are They?
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.